STRIDES PHARMA SCI LTD Valuation
STAR · Healthcare · Current price ₹1,017.6
Is STRIDES PHARMA SCI LTD undervalued?
DocStoX estimates the fair value of STRIDES PHARMA SCI LTD at ₹934 per share, versus the current market price of ₹1,018. That puts the stock about -8.2% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹373), Relative P/E (₹1,830), Graham floor (₹676), Analyst target (₹1,410). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹373 (bear) to ₹934 (base) to ₹1,830 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
STRIDES PHARMA SCI LTD trades at a P/E of 16.9x and a P/B of 3.3x, with a dividend yield of 0.5%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on STRIDES PHARMA SCI LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.